Abstract

The prevalence of systemic reactions to hymenoptera stings is up to 7.5%. Venom-specific immunotherapy (VIT) is an established treatment for insect venom allergy. In order to monitor the allergic status and thus the success of the therapy, controlled sting challenge under VIT continues to be the gold standard. This review deals not only with useful indications and therapeutic consequences but also with critical aspects that should be considered when performing sting challenge.

Author Details

Authors

• Katharina Aßmus
• Markus Meissner
• Roland Kaufmann
• Eva Maria Valesky

Departments

• Department of Dermatology, Venereology and Allergology, University Hospital, Goethe University, Frankfurt, Germany

Address

Prof. Dr. Eva Maria Valesky, Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
Email: [email protected]

Citation